'Betrayal': 6 reactions to FDA's approval of generic abortion drug

6. Health and Human Services Department

The U.S. Department of Health and Human Services building is shown Aug. 16, 2006, in Washington, D.C.
The U.S. Department of Health and Human Services building is shown Aug. 16, 2006, in Washington, D.C. | Mark Wilson/Getty Images

Andrew Nixon, a spokesperson for the Health and Human Services Department, stated that the “FDA has very limited discretion” when it comes to deciding to approve a generic drug, NBC News reported.

“By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is identical to the brand-name drug,” Nixon said in a statement.

“Generic applicants are not required to submit independent evidence proving safety and effectiveness,” he added. “HHS is conducting a study of the reported adverse effects of mifepristone to ensure the FDA’s risk mitigation program for the drug is sufficient to protect women from unstated risks.”

Samantha Kamman is a reporter for The Christian Post. She can be reached at: samantha.kamman@christianpost.com. Follow her on Twitter: @Samantha_Kamman

Was this article helpful?

Become a CP Insider.
Help keep The Christian Post free for everyone.

The truth has a cost, and Insiders help carry it.
A dollar from an Insider comes with no strings attached. It keeps our reporters on the story, keeps our journalism open to everyone, and keeps every editorial decision in the newsroom, where it belongs.

Become a CP Insider and choose the amount you want to pay. You can change, pause or cancel anytime. As a thank-you, you’ll get:

  • The Insider Newsletter, a members-only monthly letter from our newsroom

  • Ad-free reading across christianpost.com


From as low as $8.25/month
Prefer to give once?

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles.
Return to homepage.

Most Popular

More Articles